PG2 - Lung cancer: non-small cell lung cancer treatment

Postgraduate Course
Chairs: J. Vansteenkiste (Leuven, Belgium), E. Quoix (Strasbourg, France)
Aims: This is the third course in a four-year postgraduate core curriculum covering the main issues on lung cancer diagnosis and treatment. The focus of this third module in the series is on non-small cell lung cancer (NSCLC) management and treatment and the aims are:
• to address the changing trends in oncological resectability of lung cancer;
• to review the current knowledge on the optimal integration of the different components of modern multimodality treatment for NSCLC;
• to review the recent advances in NSCLC chemotherapy.

Treatment of early (stage I/II) non-small cell lung cancer G. Massard (Strasbourg, France)
Treatment of potentially resectable locoregional (stage III) non-small cell lung cancer W. Eberhardt (Essen, Germany)
Treatment of unresectable locoregional (stage III) non-small cell lung cancer D. De Ruysscher (Maastricht, The Netherlands)
Treatment of advanced non-small cell lung cancer J. Sculier (Brussels, Belgium)